This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Salmonella infection in HIV infected individuals

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek expert advice.

Salmonella is the most common bacterial cause of diarrhoea in HIV infected individuals (1).

In these individuals systemic symptoms are more marked, and though 10% have negative stool cultures the organism is often isolated on blood culture.

Following treatment 10-20% suffer a relapse, and for this reason some say treatment with 250mg b.d. ciprofloxacin should be continued for a minimum of three months (1)

Infectious Disease Society of America guidelines for the management of invasive non-typhoidal salmonella disease in HIV-infected adults recommend 2-6 weeks of fluoroquinolone therapy (2)

Reference:

  • Gazzard, B., Aids and the gastrointestinal tract. Medicine international February 1993, 21:2 pgs 44-46.
  • Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H, Centers for Disease Control and Prevention (CDC) National Institutes of Health. HIV Medicine Association of the Infectious Diseases Society of America Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1-207

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.